{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:28:53Z","timestamp":1790227733007,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.rdc.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T18:50:32Z","timestamp":1301338232000},"page":"159-171","source":"Crossref","is-referenced-by-count":45,"title":["Polymyositis and Dermatomyositis: Pathophysiology"],"prefix":"10.1016","volume":"37","author":[{"given":"Kanneboyina","family":"Nagaraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2011.01.002_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2011.01.002_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00002281-200211000-00001","article-title":"New possibilities to achieve increased understanding of disease mechanisms in idiopathic inflammatory myopathies","volume":"14","author":"Lundberg","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2011.01.002_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-201x.2001.00822.x","article-title":"The physiology of inflammatory myopathies: an overview","volume":"171","author":"Lundberg","year":"2001","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.rdc.2011.01.002_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-201x.2001.00823.x","article-title":"Immunological capabilities of skeletal muscle cells","volume":"171","author":"Nagaraju","year":"2001","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.rdc.2011.01.002_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002281-200111000-00002","article-title":"Update on immunopathogenesis in inflammatory myopathies","volume":"13","author":"Nagaraju","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2011.01.002_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2011.01.002_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar2501","article-title":"Developments in the scientific and clinical understanding of inflammatory myopathies","volume":"10","author":"Lundberg","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2011.01.002_bib8","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","article-title":"Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction","volume":"52","author":"Nagaraju","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/art.1780390521","article-title":"Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain","volume":"39","author":"Mierau","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","article-title":"The association between Mi-2 antibodies and dermatomyositis","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A\u00a0new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2011.01.002_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2011.01.002_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2011.01.002_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2011.01.002_bib15","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A\u00a0novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib16","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.rdc.2011.01.002_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2011.01.002_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A\u00a0local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib19","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/art.22790","article-title":"Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis","volume":"56","author":"Levine","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","article-title":"Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation","volume":"29","author":"Katsumata","year":"2007","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2011.01.002_bib21","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.24977","article-title":"Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle","volume":"60","author":"Mammen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rdc.2011.01.002_bib23","doi-asserted-by":"crossref","first-page":"9933","DOI":"10.1073\/pnas.87.24.9933","article-title":"The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity","volume":"87","author":"Miller","year":"1990","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2011.01.002_bib24","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","article-title":"Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy","volume":"56","author":"Stone","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI114461","article-title":"Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies","volume":"85","author":"Miller","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2011.01.002_bib26","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A\u00a0possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib27","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.24683","article-title":"Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells","volume":"60","author":"Barbasso Helmers","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib28","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies","volume":"68","author":"Krystufkova","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2011.01.002_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","article-title":"Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells","volume":"50","author":"Page","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2011.01.002_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2011.01.002_bib32","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","article-title":"Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis","volume":"58","author":"Grundtman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2011.01.002_bib34","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2011.01.002_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","article-title":"Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies","volume":"29","author":"Hohlfeld","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2011.01.002_bib36","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T\u00a0cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T\u00a0cells","volume":"183","author":"Fasth","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib37","doi-asserted-by":"crossref","first-page":"R984","DOI":"10.1186\/ar1775","article-title":"Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study","volume":"7","author":"Warrington","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.rdc.2011.01.002_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.rdc.2011.01.002_bib39","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2011.01.002_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2006.03180.x","article-title":"Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies","volume":"146","author":"Tucci","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/intimm\/dxf062","article-title":"Increased IL-15 production of muscle cells in polymyositis and dermatomyositis","volume":"14","author":"Sugiura","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1164\/rccm.2202005","article-title":"Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments","volume":"166","author":"Reid","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2011.01.002_bib43","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1096\/fj.09-144782","article-title":"Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies","volume":"24","author":"Grundtman","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.rdc.2011.01.002_bib44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.22388","article-title":"Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies","volume":"56","author":"Grundtman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jbspin.2007.07.010","article-title":"Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: a case report","volume":"75","author":"Furlan","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rdc.2011.01.002_bib46","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/art.22521","article-title":"A\u00a0new murine model to define the critical pathologic and therapeutic mediators of polymyositis","volume":"56","author":"Sugihara","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib47","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2007.079525","article-title":"Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis","volume":"67","author":"Korotkova","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2011.01.002_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1990.tb00144.x","article-title":"Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour","volume":"227","author":"Ronnblom","year":"1990","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.rdc.2011.01.002_bib49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/qjmed\/91.6.393","article-title":"Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon","volume":"91","author":"Kalkner","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.rdc.2011.01.002_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02826219","article-title":"Dermatomyositis after interferon alpha treatment","volume":"17","author":"Dietrich","year":"2000","journal-title":"Med Oncol"},{"key":"10.1016\/j.rdc.2011.01.002_bib51","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis","volume":"168","author":"Tezak","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.rdc.2011.01.002_bib53","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib54","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.20220","article-title":"Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids","volume":"50","author":"Ulfgren","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.1780380111","article-title":"Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis","volume":"38","author":"Park","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib56","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1126\/science.290.5499.2155","article-title":"Functional requirement for class I MHC in CNS development and plasticity","volume":"290","author":"Huh","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.rdc.2011.01.002_bib57","doi-asserted-by":"crossref","first-page":"17843","DOI":"10.1073\/pnas.0408154101","article-title":"A\u00a0role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy","volume":"101","author":"Oliveira","year":"2004","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2011.01.002_bib58","first-page":"35","article-title":"Non-immune functions of MHC class I glycoproteins in normal and malignant cells","volume":"50","author":"Fishman","year":"2004","journal-title":"Folia Biol (Praha)"},{"key":"10.1016\/j.rdc.2011.01.002_bib59","first-page":"141","article-title":"Immune effector mechanisms in inflammatory myopathies","volume":"68","author":"Engel","year":"1990","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10.1016\/j.rdc.2011.01.002_bib60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rdc.2011.01.002_bib61","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.41.12.2015-c","article-title":"HLA expression in myoblasts","volume":"41","author":"Hohlfeld","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2011.01.002_bib62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2249.1998.00664.x","article-title":"A\u00a0variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli","volume":"113","author":"Nagaraju","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatibility complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2011.01.002_bib64","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.10140","volume":"46","author":"Englund","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2011.01.002_bib65","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2011.01.002_bib66","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2249.1994.tb06032.x","article-title":"MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies","volume":"95","author":"Bartoccioni","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib67","first-page":"940","article-title":"Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis","volume":"27","author":"Nyberg","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2011.01.002_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-5728(02)00026-7","article-title":"Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis","volume":"125","author":"Pavlath","year":"2002","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib69","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mus.21129","article-title":"Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle","volume":"39","author":"Salomonsson","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2011.01.002_bib70","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2353\/ajpath.2009.090196","article-title":"Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis. Implications for juvenile myositis","volume":"175","author":"Li","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2011.01.002_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","article-title":"Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle","volume":"164","author":"Vattemi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2011.01.002_bib72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199407000-00008","article-title":"Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy","volume":"53","author":"De Bleecker","year":"1994","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.rdc.2011.01.002_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/clim.1999.4743","article-title":"Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells","volume":"92","author":"Nagaraju","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib74","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/ard.2004.032359","article-title":"Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors","volume":"64","author":"Chevrel","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2011.01.002_bib75","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/01.WNL.0000049913.27181.51","article-title":"Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy","volume":"60","author":"Monici","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2011.01.002_bib76","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/BOR.0b013e3283319265","article-title":"Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis","volume":"21","author":"Henriques-Pons","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2011.01.002_bib77","doi-asserted-by":"crossref","first-page":"8453","DOI":"10.1074\/jbc.M710067200","article-title":"Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy","volume":"283","author":"Lavery","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.rdc.2011.01.002_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(99)00162-9","article-title":"Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies","volume":"106","author":"Li","year":"2000","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib79","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.164.10.5459","article-title":"The inhibition of apoptosis in myositis and in normal muscle cells","volume":"164","author":"Nagaraju","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2011.01.002_bib80","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00018-009-9038-1","article-title":"Basal autophagy is involved in the degradation of the ERAD component EDEM1","volume":"66","author":"Le Fourn","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.rdc.2011.01.002_bib81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","article-title":"Inflammatory myopathies with mitochondrial pathology and protein aggregates","volume":"278","author":"Temiz","year":"2009","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.rdc.2011.01.002_bib82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4161\/auto.5.2.7391","article-title":"Denervation-induced oxidative stress and autophagy signaling in muscle","volume":"5","author":"O\u2019Leary","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.rdc.2011.01.002_bib83","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2009.01.054","article-title":"VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification","volume":"137","author":"Ramachandran","year":"2009","journal-title":"Cell"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X11000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X11000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T21:51:31Z","timestamp":1543873891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X11000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0889857X11000032"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2011.01.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}